Medtronic confronts $7 million patent lawsuit; Accelr8 completes $35M stock sale;

@FierceMedDev: We have extended the nomination deadline for the 15 fiercest medical device developers to July 13. Spread the word. Survey | Follow @FierceMedDev

 @MarkHFierce: SCOTUS upheld the whole national health reform law. The med device industry will keep opposing one of its major parts: the 2.3% industry tax. | Follow @MarkHFierce

 @DamianFierce: Changing its tune, Medtronic will sit down with the man who figured out how to hack one of its insulin pumps. Article | Follow @DamianFierce

> The New England Research Institutes in Watertown won an $18 million contract from the National Institutes of Health to develop pediatric circulatory support devices. NERI is a CRO that runs clinical trials for medical device and biotech companies. Story

> Medtronic ($MDT) faces a lawsuit from St. Louis University that accuses the company of depriving the school of at least $7 million in royalties regarding surgical navigation and imaging technology licenses. Story

> Israel's NLT Spine has generated encouraging initial clinical results from its spinal fusion device. Release

> Grove Instruments recently completed initial clinical testing of a bloodless glucometer that uses light to check blood sugar in no more than 20 seconds. Story

> Bausch + Lomb gained FDA clearance for a new one day disposable contact lens. Release

Biotech News

 @FierceBiotech: Justice Roberts is a popular man in biotech today. Biosimilars pathway and 12 year market exclusivity appear intact. | Follow @FierceBiotech

 @JohnCFierce: Quick snap on biopharma implications: Supreme Court upholds ACA, biotech threats disappear. News | Follow @JohnCFierce

> FDA offers Bayer, Onyx fast review for regorafenib. Item

> Arena basks in spotlight as FDA OKs obesity drug lorcaserin. Article

> In fresh setback Anthera shares blitzed as lupus drug flunks PhIIb. Story

> Success in PhII clears Vertex's path to late-stage study of cystic fibrosis combo. News

Pharma News

 @FiercePharma: Our quick take: With individual mandate upheld, pharma gets its new patients. More | Follow @FiercePharma

> With individual mandate upheld, pharma gets its new patients. Report

> Arena's next challenge: Build up Belviq sales. Story

> Purdue fights to extend OxyContin monopoly. Article

> Shire's Gaucher drug beats Cerezyme in bone study. News

CRO News

 @NesaNFierce: As an IU Hoosier, it's really nice to publish good news on Indiana biotech. News | Follow @NesaNFierce

> CROs or Pharma: The great innovation debate. Item

> CMO Shamrock hit with FDA warning over mislabeling. Story

> Top CRO executives predict industry's future. More

> NERI secures $18M pediatric clinical trial contract from NIH. News

Vaccines News

> Swine flu shots a success for Scotland. More

> BioDiem steps closer to a dengue vaccine. Story

> Sanofi's Hexaxim vax gets EMA thumbs up. News

> Cuban hepatitis B vax cuts disease. Item

Pharma Manufacturing News

> Daiichi Sankyo opens first U.S. manufacturing plant. News

> Merck closing Cherokee fermentation operations. More

> AMAG closing plant, moving to contract manufacturing. News

And Finally... Accelr8 Technology has consummated a deal with an investment group that will purchase up to $35 million in common stock. The company plans to use the funds to finish developing and then launch a new diagnostic system designed to identify bacterial and fungal pathogens and test their antibiotic resistance. Release

Suggested Articles

The ADDF announced its second round of research awards, with a total of $6 million in new funding for diagnostic tests.

Takeda teamed up with Enzyre to develop an at-home diagnostic device that will help people with hemophilia determine their own coagulation status.

Foundation Medicine received a diagnostic approval from the FDA for selecting HR+/HER2- breast cancer patients for treatment with Novartis' Piqray.